文献速递肾移植慢性肾脏病

肥胖肾脏捐献者的中期肾脏结局、肾衰竭与死亡率

Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.
PubMed 文献 · J Am Soc Nephrol · 2021-10-21

该研究比较了8583名肾脏捐献者按BMI分组的结局,肥胖组糖尿病、高血压和蛋白尿风险更高,但ESKD绝对风险低,死亡风险与非肥胖组无显著差异。

要点

  • 肥胖肾脏捐献者糖尿病、高血压和蛋白尿风险高于非肥胖者
  • 肥胖组捐献后前10年eGFR增幅更高,之后相似
  • 肥胖者ESKD绝对风险低,死亡风险与非肥胖者相当

核心结论

  • 肾脏捐献者肥胖与糖尿病和高血压风险增加相关,但ESKD绝对风险小且死亡风险与非肥胖捐献者相当。

研究设计与样本

  • 比较8583名肾脏捐献者按BMI分组的结局,其中BMI<30者6822人,BMI 30-34.9者1338人,BMI≥35者423人。

主要发现

  • 肥胖捐献者比非肥胖者更易发生糖尿病、高血压和蛋白尿。
  • 肥胖组与非肥胖组相比,前10年eGFR年增幅分别为3.5 ml/min per 1.73m2和2.4 ml/min per 1.73m2(P<0.001),之后相似。
  • 平均随访19.3±10.3年,非肥胖者31人(0.5%)和肥胖者12人(0.7%)发生ESKD;肥胖者12例ESKD中10例发生在与受者相关的1445名白人捐献者中(0.9%)。
  • 肥胖捐献者死亡风险较非肥胖者未显著增加。

临床怎么用

  • 肥胖不应作为排除肾脏捐献的唯一理由,需个体化评估糖尿病和高血压风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity is associated with the two archetypal kidney disease risk factors: hypertension and diabetes. Concerns that the effects of diabetes and hypertension in obese kidney donors might be magnified in their remaining kidney have led to the exclusion of many obese candidates from kidney donation. METHODS: We compared mortality, diabetes, hypertension, proteinuria, reduced eGFR and its trajectory, and the development of kidney failure in 8583 kidney donors, according to body mass index (BMI). The study included 6822 individuals with a BMI of <30 kg/m2, 1338 with a BMI of 30-34.9 kg/m2, and 423 with a BMI of ≥35 kg/m2. We used Cox regression models, adjusting for baseline covariates only, and models adjusting for postdonation diabetes, hypertension, and kidney failure as time-varying covariates. RESULTS: Obese donors were more likely than nonobese donors to develop diabetes, hypertension, and proteinuria. The increase in eGFR in obese versus nonobese donors was significantly higher in the first 10 years (3.5 ml/min per 1.73m2 per year versus 2.4 ml/min per 1.73m2 per year; P<0.001), but comparable thereafter. At a mean±SD follow-up of 19.3±10.3 years after donation, 31 (0.5%) nonobese and 12 (0.7%) obese donors developed ESKD. Of the 12 patients with ESKD in obese donors, 10 occurred in 1445 White donors who were related to the recipient (0.9%). Risk of death in obese donors was not significantly increased compared with nonobese donors. CONCLUSIONS: Obesity in kidney donors, as in nondonors, is associated with increased risk of developing diabetes and hypertension. The absolute risk of ESKD is small and the risk of death is comparable to that of nonobese donors.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ibrahim HN, Murad DN, Hebert SA, et al. Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors. J Am Soc Nephrol. 2021. PMID: 34675059. doi:10.1681/ASN.2021040548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。